- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02317289
Assisted Device for Freezing in Parkinson Disease (demarpark)
December 27, 2021 updated by: University Hospital, Montpellier
Development of a Multimodal Controlled Device for Improvement and Monitoring of Freezing in Parkinsonian Patients
Freezing of gait (FOG) is a particular and troublesome symptom occurring in some Parkinsonian patients.
Our objective is to adapt and extend FOG detectors in order to include other associated gait pattern changes, like festination.Our purpose is to develop a wearable assistant which would trigger the most appropriate cueing aid just before occurrence of the freezing episode.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
Freezing of gait (FOG) is a particular and troublesome symptom occurring in some Parkinsonian patients .This brief, episodic absence or marked reduction of forward progression of the feet despite the intention to walk is associated to a fall risk.
Automatized FOG episode detection would allow systematic assessment of patient state and objective evaluation of the clinical effects of treatments.
Techniques have been proposed in the literature to identify FOG episodes based on the frequency properties of inertial sensor signals.
Our objective here is to adapt and extend these FOG detectors in order to include other associated gait pattern changes, like festination.
The proposed approach is based on a single wireless inertial sensor placed on the patient's lower limbs.
Based freezing detectors are not sufficient to detect all FOG and festination episodes.
Stride length and cadence are valuable inputs to anticipate the occurrence of upcoming FOG events.
The investigators have developed a solution based on a minimal number of embedded sensors and detection algorithms for future real-time applications.
It is well known that auditory rhythmic stimulation or visuals marks on the ground would improve dramatically gait in patients with FOG.
This sensibility to cueing leads some teams to develop some mobility aid devices rhythmic.
Our purpose is to develop a wearable assistant which would trigger the most appropriate cueing aid just before occurrence of the freezing episode.
Study Type
Interventional
Enrollment (Actual)
26
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Montpellier, France, 34090
- Gui de Chauliac Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- troublesome freezing
Exclusion Criteria:
- dementia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Detection of freezing
freezing parkinsonian patients
|
single wireless inertial sensor placed on the patients's lower limbs to detect freezing of gaitin Parkinsonian patients
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
fog score
Time Frame: 1 day
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Christian GENY, MD, CHRU Montpellier
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 6, 2014
Primary Completion (Actual)
October 13, 2015
Study Completion (Actual)
October 13, 2015
Study Registration Dates
First Submitted
December 3, 2014
First Submitted That Met QC Criteria
December 10, 2014
First Posted (Estimate)
December 15, 2014
Study Record Updates
Last Update Posted (Actual)
December 28, 2021
Last Update Submitted That Met QC Criteria
December 27, 2021
Last Verified
December 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9096
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterRecruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
Bezmialem Vakif UniversityIstanbul University - CerrahpasaNot yet recruitingParkinson Disease | PARKINSON DISEASE (Disorder) | Parkinson Disease (PD), Postural Balance
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
Clinical Trials on Detection of freezing
-
University of HaifaTechnion, Israel Institute of Technology; Hebrew University of JerusalemRecruiting
-
Northwell HealthEMD SeronoCompleted
-
Stanford UniversityCompleted
-
V.K.V. American Hospital, IstanbulCompletedFertilization in Vitro | Preservation of Supernumerary EmbryosTurkey
-
Reproductive Medicine Associates of New JerseyTerminatedWomen Diagnosed With Cancer | Egg Donors | Single Women | Failed Sperm Procurement in IVF
-
Reproductive Medicine Associates of New JerseyTerminated
-
Rambam Health Care CampusCompleted
-
Main Line Fertility CenterMerck Sharp & Dohme LLCCompletedFertilityUnited States
-
National Taiwan University HospitalNot yet recruitingEgg Freezing | Decision Aid | Shared Decision Making | Fertility Preservation | Assisted Reproductive Technology | Oocyte Cryopreservation | Elective Egg FreezingTaiwan
-
Washington University School of MedicineCompleted